Bronchopulmonary dysplasia, Preterm newborns ≤32 weeks of gestational age. research hub

Efficacy and safety of the intratracheal administration of budesonide with surfactant in very preterm infants to prevent bronchopulmonary dysplasia: randomized clinical trial.

This study looks at giving special medicines, including a steroid, directly into the lungs of very premature babies. We want to see if this helps prevent a serious lung problem called bronchopulmonary dysplasia (BPD) and if it's safe for them.